Talks and Publications

The January 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 15, Issue 1


Biotechnology commercialisation: Getting past the technology-push PDF
Yali Friedman


Record integrity and licensing your intellectual property PDF
John Avellanet
NIH assistance for new therapeutic development: NIH-RAID Pilot Program PDF
David G Badman
Parallel imports: Towards a flexible uniform international rule PDF
Stefan M Miller
Pharmaceutical patents after KSR: What is not obvious? PDF
Jason Lief, Peter Schuyler
ATMP in practice: Towards a new industry landscape in tissue engineering PDF
Laure Brévignon-Dodin, Pawanbir Singh
Thailand biotech business: Product of the national policy PDF
Nataporn Chanvarasuth, Ramjitti Indaraprasirt

From the Classroom

Teaming in biotechnology commercialisation: The diversity-performance connection and how university programmes can make a difference PDF
Anne S York, Kim A McCarthy, Todd C Darnold

Legal and Regulatory Updates

Legal and regulatory update PDF
John Wilkinson

Book Reviews

Book Review: Science lessons: What biotech taught me about management PDF
Arthur A Boni
Book Review: Essentials of pharmacoeconomics PDF
Harley King

Last week I sent an update to my list of biotech educators about the availability of instructor resources for Building Biotechnology. I’m starting to see interest among educators who I didn’t email, so I ‘m posting a follow-up here to spread the word.

The instructor resources are free for qualified educators and include figures and tables from the text, and sample lectures. Slide decks based on each chapter are also available for a fee, and a quiz bank will be posted shortly.

The instructor resources can be accessed at here, more information on Building Biotechnology is available at here, and the list of schools which have adopted the text is here

I’m working on an International Biotechnology ranking and comparison for a well-known publication, and am looking for data sets comparing biotechnology activities in different countries as well as interesting anecdotes about successes/failures/challenges encountered in developing biotechnology in different countries as well between countries. If you’ve got comparative data sets or interesting anecdotes, please drop me a line.

The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 14, Issue 4


Continuing education in biotechnology PDF
Yali Friedman


Can compliance help marketing and business development? PDF
John Avellanet
Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers PDF
Laura Heinonen, Birgitta Sandberg
Got value? Determine it. Demonstrate it. Communicate it. Realise it PDF
Mitch DeKoven, Elisabeth H Hazard, Erica Goldberg, Shibani Pokras
Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice PDF
Kerstin M Bode-Greuel, Klaus J Nickisch

From the Classroom

Open content textbooks: Educating the next generation of bioentrepreneurs in developing economies PDF
Arlen D Meyers, Donald J McCubbrey, Richard T Watson

Legal and Regulatory Updates

Legal and regulatory update PDF
Gerry Kamstra, John Wilkinson

Book Reviews

Book Review: The Regulatory Challenge of Biotechnology PDF
John Avellanet
Book Review: Intellectual Property and Biotechnology: Biological Inventions PDF
Stefan M Miller
Book Review: Commercializing Successful Biomedical Technologies PDF
Arlen D Meyers
Book Review: Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the Biosciences PDF
Arlen D Meyers
Best Practices in Biotechnology Business Development PDF
Hans-Erik Hamid Lydecker
Genetic Glass Ceilings: Transgenics for Crop Biodiversity PDF
Drew L Kershen
Biotechnology and the Law PDF
Edward L Korwek
Welcome to Biotech Nation PDF
James Rogers

Two upcoming talks on biotechnology career development strategies at Johns Hopkins campuses:

Homewood Campus
Friday, Oct. 17th 2008 5:30-7:30pm
Remsen Hall Rm 101
3400 North Charles Street

East Baltimore Campus
Wednesday, Oct. 22nd 2008 5:30-7:30pm
Wood Basic Science Auditorium
725 Wolfe Street

Signed copies of my books will also be available for sale. For more details, contact

I’d like to build on the success of my “Best Practices in Biotechnology…” book series by producing more edited compilations focused on discrete industry topics such as:

  • Marketing
  • IP management
  • R&D management
  • Communications
  • etc.

If you are interested in leading one of these projects and editing a topical compilation, please visit the Logos Press Submission Guidelines and tell me about your vision.

Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science

460 pages
Hardcover: 978-09734676-5-9
Softcover: 978-09734676-6-6
Third Edition
August, 2008

The definitive primer and leading textbook on the business of biotechnology is now available in its third edition. This new edition is over 100 pages longer than the second edition and adds new chapters, new figures and tables, and additional case examples.

Building Biotechnology builds a robust foundation by providing a comprehensive fundamentals-based overview of the broad variety of elements influencing the commercialization of biotechnology. Expanding on this foundation to ensure a practical appreciation of operational issues in the biotechnology industry, Building Biotechnology adds real-world examples on topics such as the hidden pitfalls of common operational decisions, practical considerations in selecting business models and funding options, strategies to overcome developmental failures, and methods to leverage options to strengthen development plans.

Here’s a slideshow of a talk I recently gave at the Johns Hopkins biotechnology MS/MBA program. The purpose is to illustrate the elements which are important to consider after penning your business plan, and to help position oneself to be prepared for unexpected risks.

The material is largely drawn from my book, Building Biotechnology. Go ahead and post any questions you may have in the comments.

The March 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract of each article:

Volume 14, Issue 2


Editorial PDF
Yali Friedman


Export compliance for life sciences PDF
John Avellanet
A new approach to improve technology commercialisation in university medical schools PDF
Courtney Price, Richard Huston, Arlen D Meyers
Biotechnology business models work: Evidence from the pharmaceutical marketplace PDF
J Leslie Glick
Valuing biotechnology companies: Does classification by technology type help? PDF
Jacqueline Loh, Robert Brooks
Risk management for the biotechnology industry: A Canadian perspective PDF
Sandra Vanderbyl, Sherry Kobelak
Singapore’s biomedical sciences landscape PDF
Keat-Chuan Yeoh
Social responsibility for the use of genes, genomes and biotechnology in biotechnology companies: A commentary from the bioethical viewpoint PDF
Yoshihiro Okada, Kazuo N Watanabe

Legal and Regulatory Updates

Legal and regulatory update PDF
Gerry Kamstra, John Wilkinson

Conference Report

Maryland and Virginia unite at 2007 Mid-Atlantic Bio Conference PDF
Harley King

Book Reviews

Book Review: Stem cell wars: Inside stories from the Frontlines PDF
Grant H Skrepnek